HAL (France)open access
A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assays
Abelacimab, 0, FXIa inhibitors, Laboratory, 1, Milvexian, Interference, Coagulation assays
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 246666
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.